AIA Group Ltd Sells 7,237 Shares of HCA Healthcare, Inc. $HCA

Key Points

• AIA Group cut its HCA Healthcare stake by 76.4% in the third quarter, selling 7,237 shares and retaining 2,231 shares valued at about $952,000.
• HCA reported quarterly earnings of $7.22 per share and revenue of $19.85 billion, beating analyst estimates; revenue rose 3.6% year over year.
• HCA completed a $6.5 billion senior-notes offering and announced a quarterly dividend of $0.78 per share, equivalent to a 0.6% yield.

AIA Group Ltd lessened its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 76.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,231 shares of the company's stock after selling 7,237 shares during the period. AIA Group Ltd's holdings in HCA Healthcare were worth $952,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Provenance Wealth Advisors LLC increased its stake in HCA Healthcare by 1,260.0% during the 3rd quarter. Provenance Wealth Advisors LLC now owns 136 shares of the company's stock valued at $58,000 after buying an additional 126 shares during the period. Evergreen Private Wealth LLC lifted its position in HCA Healthcare by 5.9% in the third quarter. Evergreen Private Wealth LLC now owns 11,671 shares of the company's stock worth $4,980,000 after purchasing an additional 650 shares during the period. Factory Mutual Insurance Co. acquired a new stake in HCA Healthcare in the third quarter worth approximately $1,559,000. GRIMES & Co WEALTH MANAGEMENT LLC bought a new position in HCA Healthcare during the 3rd quarter valued at $215,000. Finally, Signature Equity Partners LLC increased its position in shares of HCA Healthcare by 2,145.5% during the 3rd quarter. Signature Equity Partners LLC now owns 494 shares of the company's stock valued at $211,000 after purchasing an additional 472 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA completed a $6.5 billion senior notes offering, providing financing that may support its capital needs; the added debt also carries obligations. HCA Healthcare Completes $6.5 Billion Senior Notes Offering
• Positive Sentiment: A Democratic midterm sweep sparked gains across hospital stocks as investors anticipated a more favorable policy environment. However, the expected relief depends on legislative action and faces a December funding fight, so the potential benefit remains uncertain. Hospital Stocks Soared as Democrats Took Congress
• Positive Sentiment: HCA plans to have 10,000 physicians using ambient AI by year-end, a rollout that could support clinical workflows and efficiency. HCA Healthcare to have 10,000 physicians on ambient AI by year-end
• Positive Sentiment: Truist reaffirmed its Buy rating, while a separate report noted a bullish technical signal after HCA moved above its 20-day average. Truist Financial Reaffirms Buy Rating for HCA Healthcare
• Neutral Sentiment: HCA’s AI chief emphasized that delaying some rollouts can be the right decision, suggesting the company is taking a measured approach to adoption. HCA Healthcare AI chief on rollouts: ‘Not yet’ can be the right call
• Negative Sentiment: A report flags payer pressure as a concern in HCA’s 2027 outlook, which could weigh on expectations if reimbursement trends worsen. HCA Healthcare stock faces payer pressure in 2027 outlook

HCA Healthcare Trading Down 0.4%

HCA Healthcare stock opened at $508.74 on Friday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The firm's fifty day simple moving average is $442.16 and its 200-day simple moving average is $445.10. The company has a market capitalization of $106.27 billion, a P/E ratio of 17.04, a P/E/G ratio of 1.71 and a beta of 1.11.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The firm had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. During the same period in the prior year, the business posted $6.96 earnings per share. The business's quarterly revenue was up 3.6% on a year-over-year basis. On average, equities research analysts predict that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare's dividend payout ratio is currently 10.34%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on HCA. Bank of America upped their price objective on HCA Healthcare from $450.00 to $500.00 and gave the company a "neutral" rating in a report on Wednesday, October 28th. UBS Group dropped their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Morgan Stanley cut their price target on shares of HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating for the company in a report on Monday, July 27th. Wells Fargo & Company raised their price objective on shares of HCA Healthcare from $381.00 to $468.00 and gave the company an "equal weight" rating in a research report on Monday. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a report on Monday, July 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $480.13.

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.